Who is sponsoring NCT03267992?

NCT03267992 is sponsored by Boston Scientific Corporation.

What drugs are being tested in NCT03267992?

Interventions in NCT03267992: COPD Co-Pilot AIR App.

What condition does NCT03267992 study?

NCT03267992 studies COPD Symptoms After Coil Procedure.

Is NCT03267992 still recruiting?

NCT03267992 is currently terminated. Last updated 16 July 2021.

Last reviewed 2021-07-16 · How we verify

NCT03267992: Co-Pilot Air

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chronic Obstructive Pulmonary Disease (COPD) Co-Pilot AIR Substudy of CLN0014

Terminated Last updated 16 July 2021

What this trial tests

trial testing COPD Co-Pilot AIR App in COPD Symptoms After Coil Procedure in 9 participants. Terminated before completion.

Timeline

10 February 2017

Primary endpoint
20 October 2018

20 October 2018

Quick facts

Lead sponsor	Boston Scientific Corporation
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	9
Start date	10 February 2017
Primary completion	20 October 2018
Estimated completion	20 October 2018
Sites	2 locations across Switzerland

Drugs / interventions tested

COPD Co-Pilot AIR App

Conditions studied

COPD Symptoms After Coil Procedure — all drugs for COPD Symptoms After Coil Procedure →

Sponsor

Boston Scientific Corporation — full company profile →

Who can join

18 and older, any sex, with COPD Symptoms After Coil Procedure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of undertaking CLN0020, which was a Substudy of the European Coil registry (CLN0014), was to investigate the use of COPD Co-Pilot AIR™, a COPD disease management program manufactured and operated by HGE Health Care Solutions, LLC, in participants undergoing the PneumRx Endobronchial Coil Treatment in a post-market setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Boston Scientific Corporation trials

Trials by the same sponsor.

NCT07458243 — Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT · not yet recruiting
NCT07458217 — Combined CM and STN Stimulation for Motor Epilepsy · NA · not yet recruiting
NCT07276815 — OverStitch NXT Endoscopic Suture System · NA · not yet recruiting
NCT07353710 — A Study on the Acquisition of 2D ICE Images With the CHORUS IDx System in Subjects Undergoing an Ablation Procedure · NA · not yet recruiting
NCT07195708 — Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365') · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03267992 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Boston Scientific Corporation
Last refreshed: 16 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03267992.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing